| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Angiodynamics Inc (ANGO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. ANGO is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 882.5K | $10.72M | - | |
| CFO | 256.6K | $3.12M | - | |
| Dir | 167.1K | $2.03M | - | |
| Dir | 143.5K | $1.74M | - | |
| Dir | 105.0K | $1.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2017 | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 2,350,000 | $16.00 | $37,600,000.00 | -50.2% | |
| Apr 12, 2017 | Burgstahler David F | Director, 10% Owner | Sell | 2,350,000 | $16.00 | $37,600,000.00 | -50.2% | |
| Nov 18, 2016 | Burgstahler David F | Director, 10% Owner | Sell | 2,091,294 | $15.68 | $32,791,489.92 | -34.8% | |
| Nov 18, 2016 | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 2,091,294 | $15.68 | $32,791,489.92 | -34.8% | |
| Aug 5, 2016 | Burgstahler David F | Director, 10% Owner | Sell | 2,250,000 | $14.62 | $32,895,000.00 | -23.9% | |
| Aug 5, 2016 | Avista Capital Partners Gp, LLC | 10% Owner | Sell | 2,241,000 | $14.62 | $32,763,420.00 | -23.8% | |
| May 6, 2016 | Greiner Charles R | VP - Global Franchise | Sell | 3,508 | $12.31 | $43,183.48 | -14.4% | |
| Apr 25, 2016 | Trowbridge Stephen A | SVP And General Counsel | Sell | 12,940 | $12.30 | $159,184.20 | -17.2% | |
| Feb 13, 2015 | Richard Stark | SVP, Gm - Oncology | Sale+OE | 18,100 | $18.53 | $335,393.00 | -38.7% |